Single cell network profiling (SCNP): Mapping drug and target interactions

Assay and Drug Development Technologies

Volumn 8, Issue 3, 2010, Pages 320-338

  Covey, Todd M ^a   Putta, Santosh ^a   Cesano, Alessandra ^a  

^a Nodality Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [N [1 (2 CYANO 1 OXOETHYL) 4 METHYL 3 PIPERIDINYL] N METHYLAMINO]PYRROLO[2,3 D]PYRIMIDINE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CD40 LIGAND; CUCURBITACIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; JANUS KINASE 2 INHIBITOR; JANUS KINASE 3 INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PYRIDONE 6; STAT1 PROTEIN; STAT3 PROTEIN; STAT3 PROTEIN INHIBITOR; STAT5 PROTEIN; UNCLASSIFIED DRUG; UO 126;

ARTICLE; B LYMPHOCYTE; CELL SUBPOPULATION; CELL TYPE; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; DRUG TARGETING; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; IC 50; LEUKOCYTE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SINGLE CELL NETWORK PROFILING; T LYMPHOCYTE;

EID: 77954517287     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2009.0251     Document Type: Article

References (36)

1. Loscalzo J , Kohane I , Barabasi AL : Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol 2007 ; 3 : 124.
2. Augen J : Industrialized molecular biology, information biotechnology, and the blockbuster drug model-alive and well at age 50. Drug Discov Today 2002 ; 7 : S157-S159.
3. Hopkins AL : Network pharmacology. Nat Biotechnol 2007 ; 25 : 1110-1111.
4. Hocquette JF : Where are we in genomics? J Physiol Pharmacol 2005 ; 56 (Suppl 3) : 37-70.
5. Hu G , Agarwal P : Human disease-drug network based on genomic expression profiles. PLoS ONE 2009 ; 4 : e6536.
6. Middleton FA , Rosenow C , Vailaya A , Kuchinsky A , Pato MT , Pato CN : Integrating genetic, functional genomic, and bioinformatics data in a systems biology approach to complex diseases: application to schizophrenia. Methods Mol Biol 2007 ; 401 : 337-364.
7. Nacher JC , Schwartz JM : A global view of drug-therapy interactions. BMC Pharmacol 2008 ; 8 : 5.
8. Schrattenholz A , Soskic V : What does systems biology mean for drug development? Curr Med Chem 2008 ; 15 : 1520-1528.
9. Zhu J , Zhang B , Schadt EE : A systems biology approach to drug discovery. Adv Genet 2008 ; 60 : 603-635.
10. Aardema MJ , MacGregor JT : Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies. Mutat Res 2002 ; 499 : 13-25.
11. Irish JM , Czerwinski DK , Nolan GP , Levy R : Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. Blood 2006 ; 108 : 3135-3142.
12. Irish JM , Czerwinski DK , Nolan GP , Levy R : Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry. J Immunol 2006 ; 177 : 1581-1589.
13. Irish JM , Hovland R , Krutzik PO , Perez OD , Bruserud O, Gjertsen BT, e t al. : Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004 ; 118 : 217-228.
14. Irish JM , Kotecha N , Nolan GP : Mapping normal and cancer cell signalling networks: towards single-cell proteomics. Nat Rev Cancer 2006 ; 6 : 146-155.
15. Krutzik PO , Crane JM , Clutter MR , Nolan GP : High-content single-cell drug screening with phosphospecific flow cytometry. Nat Chem Biol 2008 ; 4 : 132-142.
16. Zhang JH , Chung TD , Oldenburg KR : A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 1999 ; 4 : 67-73.
17. R: A language and environment for statistical computing [computer program]. Version. R Foundation for Statistical Computing, Vienna, Austria, 2004.
18. Vlahos CJ , Matter WF , Hui KY , Brown RF : A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994 ; 269 : 5241-5248.
19. Thompson JE , Cubbon RM , Cummings RT , Wicker LS , Frankshun R , Cunningham BR , et al.: Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor. Bioorg Med Chem Lett 2002 ; 12 : 1219-1223.
20. Kirken RA , Rui H , Malabarba MG , Howard M , Kawamura M , Shea JJ , et al.: Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain. Cytokine 1995 ; 7 : 689-700.
21. Donahue AC , Kharas MG , Fruman DA : Measuring phosphorylated Akt and other phosphoinositide 3-kinase-regulated phosphoproteins in primary lymphocytes. Meth Enzymol 2007 ; 434 : 131-154.
22. Krutzik PO , Clutter MR , Nolan GP : Coordinate analysis of murine immune cell surface markers and intracellular phosphoproteins by flow cytometry. J Immunol 2005 ; 175 : 2357-2365.
23. Krutzik PO , Hale MB , Nolan GP : Characterization of the murine immunological signaling network with phosphospecific flow cytometry. J Immunol 2005 ; 175 : 2366-2373.
24. Krutzik PO , Irish JM , Nolan GP , Perez OD : Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. Clin Immunol 2004 ; 110 : 206-221.
25. Krutzik PO , Nolan GP : Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A 2003 ; 55 : 61-70.
26. Perez OD , Krutzik PO , Nolan GP : Flow cytometric analysis of kinase signaling cascades. Methods Mol Biol 2004 ; 263 : 67-94.
27. Perez OD , Mitchell D , Campos R , Gao GJ , Li L , Nolan GP : Multiparameter analysis of intracellular phosphoepitopes in immunophenotyped cell populations by flow cytometry. Curr Protoc Cytom 2005 ; Chapter 6 : Unit 6.20.
28. Perez OD , Nolan GP : Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat Biotechnol 2002 ; 20 : 155-162.
29. Perez OD , Nolan GP : Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level. Immunol Rev 2006 ; 210 : 208-228.
30. Covey T , Mu S , Saris CJM : Monitoring signal transduction in whole blood by flow cytometry. Paper presented at the Experimental Biology FASEB , San Diego, CA , 2005.
31. Changelian PS , Flanagan ME , Ball DJ , Kent CR , Magnuson KS, Martin WH, e t al. : Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science 2003 ; 302 : 875-878.
32. McCaffery I, Fitzpatrick VD, Wang SW, Rossi J, Suggs SV, Bao H, e t al. : Translation of protein biomarkers for clinical development. In: Clinical Proteomics: From Diagnosis to Therapy ( Dunn MJ , ed.), Wiley, Weinheim , Germany , 2008 ; 633-650
33. Sklar LA , Carter MB , Edwards BS : Flow cytometry for drug discovery, receptor pharmacology and high-throughput screening. Curr Opin Pharmacol 2007 ; 7 : 527-534.
34. Krutzik PO , Nolan GP : Fluorescent cell barcoding in flow cytometry allows highthroughput drug screening and signaling profiling. Nat Methods 2006 ; 3 : 361-368.
35. Elliott GS , Escobar S , Stanton R , Rowe T , Gulrajani M , Walling L , et al.: Posttreatment pooling: A simple method to enhance sample throughput for screening small molecule libraries. Paper presented at the International Society for Analytical Cytology XXIV, Budapest, Hungary, 2008.
36. Motlekar N , Diamond SL , Napper AD : Evaluation of an orthogonal pooling strategy for rapid high-throughput screening of proteases. Assay Drug Dev Technol 2008 ; 6 : 395-405.